Navigate today’s most pressing health industry challenges with a leading global expert by your side.
Discover intelligent digital solutions to help improve outcomes, manage costs, and solve the toughest healthcare challenges.
Meet growing needs for innovative insurance solutions while increasing operational health and improving compliance.
Property & casualty advisory services
Modern flood insurance program
Investment, advisory & trading services
Financial modeling & industrialization
Insurance risk assessment
Geographic rating insights
Premium comparison platform
Retirement & Benefits
Deliver on the promises of the past and create smart solutions for the future.
Pension administration & communication
Retirement benefits administration platform
Compensations & benefits
Benefit plan evaluation
Health & welfare benefits administration platform
Manage complex risks using data-driven insights, advanced approaches, and deep industry experience.
Auto policy underwriting
Software performance enhancement
Mortgage platform for investments & reinsurance
Solvency II reporting & compliance
This is a place where your ideas and insights make an impact. Where an independent, entrepreneurial spirit is an advantage. And where diversity of thought and experience makes us who we are.
Data-driven insight. Deep expertise. Transformative innovation. Since 1947, Milliman has delivered intelligent solutions to improve health and financial security.
Ellyn Russo is a healthcare consultant with Milliman’s Hartford, Connecticut office. She joined the firm in 2020.
Ellyn provides value to clients by designing and synthesizing analyses to quantify healthcare delivery and health outcomes for various health states and healthcare interventions across all U.S. healthcare markets.
Prior to joining Milliman, Ellyn amassed a decade of experience analyzing and presenting healthcare data for regulatory reporting, quality improvement, and research purposes. She has authored and co-authored manuscripts published in peer-reviewed journals on Clostridioides difficile infection and the safety and effectiveness of antibiotics and influenza vaccines.